Biomatics Capital Partners is a Seattle-based healthcare and life sciences venture firm.
Biomatics Capital Partners is a Seattle-based healthcare and life sciences venture firm. Biomatics is a $200 million fund that focuses on early-stage investments, primarily in genomics and digital health. Co-founders and General Partners Dr. Boris Nikolic and Julie Sunderland have invested together in emerging technology, health care, and life science ventures since 2010, leveraging their deep technical knowledge and partnering expertise with an established network of leading academics, pharma executives and venture capital firms.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 19, 2021
Verve Therapeutics
|
Series B | $94M | Biotechnology | — |
Jun 11, 2020
Verve Therapeutics
|
Series A | $63M | Biotechnology | — |
May 7, 2019
Verve Therapeutics
|
Series A | $58.50M | Biotechnology | — |
Jun 14, 2017
Twist Bioscience
|
Series Unknown | $27M | Biotechnology | Yes |